Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 12/20 | 0.41 |
| ▸ | PGR | P06401 | 1/20 | 0.41 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.37 |
| ▸ | CUL4A | Q13619 | 1/20 | 0.37 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.37 |
| ▸ | BCAT1 | P54687 | 1/20 | 0.37 |
| ▸ | TRPV4 | Q9HBA0 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1994873 | 1.00 | AR (0.41) | ARPGRSLC22A12CUL4APDK2 | |
| SCHEMBL25983090 | 0.87 | AR (0.46) | ARPGRSLC22A12PDK2TSHR | |
| SCHEMBL17030741 | 0.82 | TSHR (0.39) | ARPGRSLC22A12CUL4APDK2 | |
| SCHEMBL2047143 | 0.79 | HCAR1 (0.35) | — | |
| SCHEMBL20455609 | 0.79 | TRPA1 (0.33) | — | |
| SCHEMBL29890653 | 0.79 | TRPA1 (0.33) | — | |
| SCHEMBL3911267 | 0.79 | AR (0.46) | ARPGRSLC22A12 | |
| SCHEMBL2658869 | 0.78 | AR (0.40) | ARPGRPDK2TSHR | |
| SCHEMBL5228912 | 0.78 | TSHR (0.54) | ARPGRTSHR | |
| SCHEMBL16960191 | 0.78 | AR (0.40) | ARPGRPDK2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114014850-A | Prudelamine intermediate, synthesis method thereof and method for synthesizing prasulamine from intermediate | 山东汇海医药化工有限公司 | 2022-02-08 | — | — | CN | claimed |
| CN-118574821-A | Compounds and their use in the treatment of cancer | 阿斯利康(瑞典)有限公司 | 2024-08-30 | — | — | CN | disclosed |
| CN-116848116-A | Novel compounds as dual androgen receptor and phosphodiesterase inhibitors | 日东制药株式会社 | 2023-10-03 | — | — | CN | disclosed |
| CN-116348458-A | Imidazolylpyrimidinylamine compounds as CDK2 inhibitors | 因赛特公司 | 2023-06-27 | — | — | CN | disclosed |
| WO-2022063437-A1 | COMPOSITIONS FOR THE TREATMENT OF SALIVARY GLAND CARCINOMA | JANSSEN PHARMACEUTICA NV (BE) | 2022-03-31 | — | — | WO | disclosed |